Beroni Group Limited (BNIGF)
Beroni Group Limited operates in the Biotechnology industry of the Healthcare sector, headquartered in Sydney, NSW, AU. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $212,760. On trailing twelve-month figures it carries a trailing P/E of -0.06, a net margin of -661.7%. Its beta of -1.76 implies it has historically moved less than the broad market.
Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of FDA/CE approved virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products, and a development pipeline targeting oncology and cell therapies. The company has operations in Australia, the United States, China, and Japan.
Beroni Group Limited is most often compared with the following Healthcare names: